These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9869044)

  • 1. Treatment of ornithine transcarbamylase deficiency in girls by auxiliary liver transplantation: conceptual changes in a living-donor program.
    Kasahara M; Kiuchi T; Uryuhara K; Ogura Y; Takakura K; Egawa H; Asonuma K; Uemoto S; Inomata Y; Tanaka K
    J Pediatr Surg; 1998 Dec; 33(12):1753-6. PubMed ID: 9869044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategy used to overcome graft atrophy in auxiliary partial orthotopic liver transplantation from a living donor for ornithine transcarbamylase deficiency.
    Kaibori M; Egawa H; Inomata Y; Uemoto S; Asonuma K; Kiuchi T; Varela-Fascinetto G; Matsukura T; Kasahara M; Uryuhara K; Inui A; Komatsu H; Fujisawa T; Tanaka K
    Transplant Proc; 1998 Nov; 30(7):3221-2. PubMed ID: 9838424
    [No Abstract]   [Full Text] [Related]  

  • 3. Severe late acute allograft rejection in a child after living-related auxiliary partial orthotopic liver transplantation for ornithine transcarbamylase deficiency.
    Komatsu H; Inui A; Fujisawa T; Sogo T; Miyagawa Y; Inui M; Uemoto S; Inomata Y; Tanaka K
    Clin Transplant; 1999 Aug; 13(4):300-4. PubMed ID: 10485370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexistence of a graft with the preserved native liver in auxiliary partial orthotopic liver transplantation from a living donor for ornithine transcarbamylase deficiency.
    Uemoto S; Yabe S; Inomata Y; Nishizawa H; Asonuma K; Egawa H; Kiuchi T; Okajima H; Yamaoka Y; Yamabe H; Inui A; Fujisawa T; Tanaka K
    Transplantation; 1997 Apr; 63(7):1026-8. PubMed ID: 9112359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of orthotopic liver transplantation in the treatment of ornithine transcarbamylase deficiency.
    Busuttil AA; Goss JA; Seu P; Dulkanchainun TS; Yanni GS; McDiarmid SV; Busuttil RW
    Liver Transpl Surg; 1998 Sep; 4(5):350-4. PubMed ID: 9724471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Auxiliary partial orthotopic liver transplantation from a living related donor: a report of two cases.
    Egawa H; Tanaka K; Inomata Y; Uemoto S; Okajima H; Satomura K; Kiuchi T; Yabe S; Nishizawa H; Yamaoka Y
    Transplant Proc; 1996 Apr; 28(2):1071-2. PubMed ID: 8623230
    [No Abstract]   [Full Text] [Related]  

  • 7. Hyperammonemia in ornithine transcarbamylase-deficient recipients following living donor liver transplantation from heterozygous carrier donors.
    Rahayatri TH; Uchida H; Sasaki K; Shigeta T; Hirata Y; Kanazawa H; Mali V; Fukuda A; Sakamoto S; Kasahara M
    Pediatr Transplant; 2017 Feb; 21(1):. PubMed ID: 27891735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histological improvement in native liver after auxiliary partial liver transplantation for ornithine transcarbamylase deficiency.
    Inui A; Fujisawa T; Komatsu H; Tanaka K; Inui M
    Lancet; 1996 Sep; 348(9029):751-2. PubMed ID: 8806305
    [No Abstract]   [Full Text] [Related]  

  • 9. Functional portal flow competition after auxiliary partial orthotopic living donor liver transplantation in noncirrhotic metabolic liver disease.
    Kasahara M; Takada Y; Kozaki K; Uryuhara K; Ogura Y; Ogawa K; Fujimoto Y; Tanaka K
    J Pediatr Surg; 2004 Jul; 39(7):1138-41. PubMed ID: 15213919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Living related liver transplantation for patients with ornithine transcarbamylase deficiency].
    Tazuke M; Murakawa M; Nakao S; Mukaida K; Toda H; Mori K
    Masui; 1997 Jun; 46(6):783-7. PubMed ID: 9223881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of serious illness in heterozygotes for ornithine transcarbamylase deficiency.
    Batshaw ML; Msall M; Beaudet AL; Trojak J
    J Pediatr; 1986 Feb; 108(2):236-41. PubMed ID: 3944708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Auxiliary partial orthotopic living donor liver transplantation for fulminant hepatic failure with flat electroencephalogram: a case report.
    Kobayashi T; Sato Y; Yamamoto S; Takeishi T; Oya H; Hideki N; Kokai H; Kurosaki I; Hatakeyama K
    Transplant Proc; 2010 Apr; 42(3):990-3. PubMed ID: 20430223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orthotopic liver transplantation for ornithine transcarbamylase deficiency with hyperammonemic encephalopathy.
    Hasegawa T; Tzakis AG; Todo S; Reyes J; Nour B; Finegold DN; Starzl TE
    J Pediatr Surg; 1995 Jun; 30(6):863-5. PubMed ID: 7666324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful living donor liver transplantation plus domino-auxiliary partial orthotopic liver transplantation for pediatric patients with metabolic disorders.
    Dong C; Song Z; Meng X; Sun C; Wang K; Yang Y; Qin H; Han C; Zhang F; Zheng W; Gao W
    Pediatr Surg Int; 2020 Dec; 36(12):1443-1450. PubMed ID: 33040172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver transplantation in urea cycle disorders.
    Saudubray JM; Touati G; Delonlay P; Jouvet P; Narcy C; Laurent J; Rabier D; Kamoun P; Jan D; Revillon Y
    Eur J Pediatr; 1999 Dec; 158 Suppl 2():S55-9. PubMed ID: 10603100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amino acid and DNA analyses in a family with ornithine transcarbamylase deficiency.
    Hou JW; Wang TR
    J Formos Med Assoc; 1996 Feb; 95(2):144-7. PubMed ID: 9064003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocyte transplantation followed by auxiliary liver transplantation--a novel treatment for ornithine transcarbamylase deficiency.
    Puppi J; Tan N; Mitry RR; Hughes RD; Lehec S; Mieli-Vergani G; Karani J; Champion MP; Heaton N; Mohamed R; Dhawan A
    Am J Transplant; 2008 Feb; 8(2):452-7. PubMed ID: 18211511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective portal blood flow diversion in auxiliary partial orthotopic liver transplantation to induce regeneration of the graft.
    Kaibori M; Egawa H; Inomata Y; Uemoto S; Asonuma K; Kiuchi T; Varela-Fascinetto G; Matsukura T; Kasahara M; Uryuhara K; Inui A; Komatsu H; Fujisawa T; Tanaka K
    Transplantation; 1998 Oct; 66(7):935-7. PubMed ID: 9798708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Living donor liver transplantation for noncirrhotic inheritable metabolic liver diseases: impact of the use of heterozygous donors.
    Morioka D; Takada Y; Kasahara M; Ito T; Uryuhara K; Ogawa K; Egawa H; Tanaka K
    Transplantation; 2005 Sep; 80(5):623-8. PubMed ID: 16177636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Auxiliary liver transplantation for urea-cycle enzyme deficiencies: lessons from three cases.
    Kiuchi T; Edamoto Y; Kaibori M; Uryuhara K; Kasahara M; Uemoto S; Egawa H; Inomata Y; Tanaka K
    Transplant Proc; 1999; 31(1-2):528-9. PubMed ID: 10083221
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.